V-SEA is the transforming component of S13 Avian Erythroblastosis Retrovirus that causes erythroblastosis and anemia in chicken. Like all members in the family (MET, RON, SEA), its cytosolic domain possesses two tyrosine autophosphorylation sites in the tandemly arranged bidentate motif that serve as docking sites for SH2 domain-containing proteins. Here, we investigated phosphotyrosine-dependent activation of signaling pathways and their signi®cance in V-SEA-induced transformation and/or proliferation. We demonstrated that V-SEA activates the PI3K-Akt signaling pathway primarily in Y557-and secondarily in Y564-dependent manner. V-SEA was also shown to induce the tyrosine phosphorylation of the Gab2 protein, leading to PI3K association and thus providing an alternative route for PI3K activation. On the other hand, activation of the Ras-ERK pathway is primarily via Y564 and secondarily via Y557. A dominant-negative form of Ras inhibited V-SEA-induced ERK phosphorylation in concentration dependent manner suggesting the importance of the Grb2-Ras signaling axis in V-SEA-induced ERK activation. The biological signi®cance of activation of the PI3K-Akt and the Ras-ERK pathways in V-SEAinduced transformation was analysed in the V-SEA-RAT1 and V-SEA-3T3 cell lines by employing speci®c inhibitors, LY294002 and PD98059 compounds. Both the PD and LY compounds inhibited cell growth, but only the PD compound caused reversion of the transformed phenotype. In addition, both compounds inhibited focal colony formation by the transformants in soft agar. Thus, transformation by the V-SEA oncogene is a function of the concomitant activation of, at least, the PI3K-Akt and Ras-ERK signaling pathways that regulate cell growth and morphology.
Introduction
Binding of a polypeptide growth factor to a cognate receptor tyrosine kinase (RTK) on a cell surface induces explicit cellular signals that control growth, dierentiation and survival. Structural alterations that lead to changes in the biological activity of these receptors disrupt the delicate physiological balance and may eventually result in uncontrolled cell proliferation and development of cancer. For instance, the hepatocyte growth factor (HGF) receptor (MET) and the nerve growth factor (NGF) receptor (TRK) become oncogenes upon truncation and fusion with unrelated cellular sequences (tpr-MET and tpr-TRK, tpr for translocated promoter region) (Cooper et al., 1984; Park et al., 1986; Greco et al., 1992; Fixman et al., 1996) . Similarly, c-SEA (SEA for sarcoma, erythroblastosis and anemia) becomes an oncogene upon fusion of its tyrosine kinase domain (TKD) with viral env gene (V-SEA) (Hayman et al., 1985) . In all cases, these structural changes cause constitutive activation of the tyrosine-kinase domain in a ligand-independent manner. In the case of tpr-MET and tpr-TRK oncogenes, acquisition of the tpr sequence, which contains leucine-zipper motifs, results in dimerization, autophosphorylation and constitutive activation (Park et al., 1986; Greco et al., 1992) . Similarly, the viral envelope protein sequences in V-SEA promote`receptor' dimerization, autophosphorylation and constitutive activation (Smith et al., 1989; Morimoto and Hayman, 1994) .
V-SEA was originally identi®ed as the transforming component of S13 Avian Erythroblastosis Retrovirus that causes erythroblastosis and anemia in chicken (Hayman et al., 1985) . The extracellular, transmembrane and juxtamembrane domains are encoded by viral sequences, whereas the cytosolic region that has the TKD and conserved tyrosine phosphorylation sites is encoded by c-SEA sequences (Smith et al., 1989 ) (see Figure 1 ). The V-SEA gene is translated as a 155 KDa precursor glycoprotein, which becomes cleaved into 85 and 70 KDa`subunits', which are linked by a disul®de bridge (Hayman et al., 1985) . Analogous to ligandinduced dimerization of RTKs, the 85 KDa subunit mediates physical association between V-SEA molecules and in doing so induces autophosphorylation and constitutive activation of the TKD (Smith et al., 1989) . Thus, acquisition of the viral envelope protein sequences is central to V-SEA's oncogenicity.
The proto-oncogene c-SEA belongs to the hepatocyte growth factor receptor subfamily of tyrosine kinases (Hu et al., 1993) that include MET and RON (Cooper et al., 1984; Park et al., 1984; Cowley et al., 1994) . All members of the family possess two conserved tyrosine residues in their C-terminal domain that are essential for transducing diverse biological signals (Hu et al., 1993; Cowley et al., 1994; Ponzetto et al., 1993) . In MET and RON, autophosphorylation of the two tyrosines is induced by the binding of the respective ligands, the hepatocyte growth factor (HGF) and macrophage stimulating protein (MSP). These phosphotyrosines serve as high-anity docking sites for SH2 or PTB domain-containing proteins and in doing so eect the relaying of ligand-induced signals down the cascade (Ponzetto et al., 1993; Tulasne et al., 1999) . Activation of MET induces cell morphogenesis and scattering, mainly in cells of epithelial origin, via activating the Ras and the PI3K signaling pathways; mutation of these tyrosines abrogates this potential (Potempa and Ridley, 1998; Royal et al., 2000) . Similarly, activation of RON induces growth in various cell types and this potential is eliminated upon mutation of the conserved tyrosines (Iwama et al., 1996) . Recently, the chicken macrophage stimulating protein (cMSP) that acts as a high-anity ligand to c-SEA has been identi®ed (Wahl et al., 1999) , but its biological signi®cance is yet to be established. As in MET and RON, the two tyrosines are essential for cMSP-induced c-SEA activation of ERK1/2 (Wahl et al., 1999) .
In V-SEA, the two tyrosines in the tandemly arranged motif, designated as Y557 and Y564, are shown to be essential for transformation of rat ®broblasts and chicken erythroblasts (Hayman et al., 1985) ; mutation of both tyrosines to phenylalanine abrogates this potential (Park and Hayman, 1999) . Furthermore, it was demonstrated that Y557 serves as a primary binding site for the p85 subunit of PI3K, whereas Y564 for Grb2 (Park and Hayman, 1999) . However, neither the consequences of these interactions as regards the signaling molecules and/or pathway(s) that become activated nor the importance of these in V-SEA-induced transformation were investigated. Here, we show that transient transfection of V-SEA into COS-1 cells activates the PI3K-Akt and the Ras-ERK pathways. We speci®cally show that Y557 primarily mediates the activation of PI3K and to a lesser degree ERK1/2; the vice versa is true for Y564. These data indicate that each tyrosine serves as a major site for the activation of one pathway with the ability to serve as a minor site for activation of the alternative pathway. We also demonstrated that the Grb2-associated-binding protein 2, Gab2, is tyrosine phosphorylated in V-SEA transformed cells and is associated with PI3K. In addition, the results presented in this report show that in-concert functioning of, at least, the PI3K-Akt and the Ras-ERK signaling pathways is absolutely essential for V-SEA-induced transformation of Rat-1 and NIH3T3 cells.
Results
Amino acids Y557 and Y564 of V-SEA were shown to be the major autophosphorylation sites and, once phosphorylated, serve as docking sites for the p85 subunit of PI3K and Grb2, respectively (Park and Hayman, 1999) . The current study further pursued this observation with the aim to decipher the biochemical and biological signi®cance of these interactions. First, we examined pathways that likely become activated by these interactions: the PI3K-Akt and the Ras-ERK. And second, we evaluated the biological signi®cance of the PI3K-Akt and the Ras-ERK signaling pathways in V-SEA-transformed Rat-1 ®broblasts and NIH3T3 cells.
V-SEA activates PI3K
To assess the biochemical consequence of the V-SEA-PI3K interaction, we transiently transfected COS-1 cells with WT-V-SEA or with single or double tyrosineto-phenylalanine mutants. A V-SEA construct whose PI3K binding site was doubled by changing the three residues C-terminal to Y564 to that of Y557, designated as Y557 2 (Park and Hayman, 1999) , was also included in this study. The dierent V-SEA proteins were isolated by immune precipitation and the associated PI3K activity measured as described in Materials and methods. Expression of WT-V-SEA induced a 3.5-fold over basal increase in V-SEAassociated PI3K activity and this was elevated to 5.5-fold when the PI3K binding site was doubled ( Figure   Figure 1 Schematic representation of the hepatocyte growth factor receptor family members and V-SEA. The mature forms of all members in the family are heterodimers with an a chain that is completely extracellular (EC) and a b chain that has an EC, a transmembrane (TM) and an intracellular (IC) domains. V-SEA also has two disul®de-linked subunits: p85 subunit solely from viral env protein forming the EC region and a membranespanning IC subunit (p70) . Also, Y564F, which contains an intact PI3K binding site induced a PI3K activity of threefold over basal. However, Y557F, which lacks the speci®c PI3K binding site increased PI3K activity by only 1.8-fold over basal, which is approximately 20% of the activity induced by the wild type. In contrast, the double mutant, which lacks both tyrosines did not cause any appreciable change in PI3K activity. A similar pattern, but with a slightly increased activity was obtained when a direct PI3K assay was determined (data not shown). V-SEA-induced activation of PI3K was further evaluated by determining the phosphorylation of Akt (also known as protein kinase B, PKB), known to be one of the downstream eectors of PI3K. All constructs that contain intact Y557 including WT-V-SEA, Y557
2 and Y564F induced a stronger phosphorylation of Akt. On the other hand, the Y557F mutant induced a weaker Akt phosphorylation, but the double mutant Y557/564F did not cause any detectable phosphorylation (Figure 2b ). Together, these results suggest that V-SEA-induces the PI3K-Akt pathway and that this induction is primarily Y557 dependent and to a lesser degree Y564 dependent.
V-SEA activates the Ras-ERK pathway
The interaction of Grb2 with V-SEA is essentially Y564-dependent (Park and Hayman, 1999) , an interaction that could activate the Ras-ERK pathway. To address this question, we ®rst determined the activation of ERK1/2 by the various V-SEA proteins described above. As expected, WT-V-SEA and the Y557F mutant (with intact Y564) induced a strong ERK1/2 phosphorylation, where the phosphorylation induced by the Y557 2 and Y564F mutants was relatively weaker (Figure 3a) . On the other hand, there was no detectable ERK1/2 phosphorylation induced by the double mutant Y557/564F. These data were slightly dierent from our previous analysis of the activation of ERK1/2 activity by these mutants using a gel-shift assay (Park and Hayman, 1999) . Thus, we decided to directly determine the activation of ERK1/2 by the various V-SEA proteins by conducting ERK2 kinase assay using myelin basic protein as a substrate (see Materials and methods for details). WT-V-SEA induced 6.5-fold over basal ERK2 activity, whereas Y577F, which contains intact Y564, induced *®vefold (Figure 3b ). On the other hand, Y557 2 which has`two' intact Y557 induced *threefold over basal, and the Y564F with one intact Y557, *2.5-fold over basal (Figure 3b ). These results are consistent with those obtained using the phosphospeci®c antibodies ( Figure 3a ) and indicate that signi®cant activation of the ERK1/2 pathways can also occur via Y557.
Previously, we had used micro-injection of Gst-Grb2 SH2 domain fusion proteins to show that if we blocked association of signaling molecules with these tyrosines we blocked transformation. But these experiments did not address the issue if this was solely due to Ras activation, since this fusion protein would block the association of all signaling molecules. In order to accomplish this task, we cotransfected a constant amount of WT-V-SEA and varying amounts of the dominant negative form of H-Ras (N17-Ras) and determined the phosphorylation level of ERK1/2, its downstream eector proteins. N17-Ras inhibited V-SEA-induced ERK phosphorylation in concentration dependent manner with EC 50 of approximately 1 ± 2 mg per 10 6 cells seeded onto 6 cm dish ( Figure 3c ). However, coexpression of WT-Ras did not aect V-SEA-induced ERK phosphorylation. Together, these results suggest that V-SEA-Grb2 interaction, primarily through Y564, culminates in the activation of the Ras-ERK pathway.
The effect of PD98059 or LY294002 compound on the morphology of V-SEA-RAT1 or V-SEA-3T3 cells As demonstrated above, V-SEA activates the Ras-ERK and the PI3K-Akt signaling pathways in COS-1 cells and can do so via either of the two tyrosines in the bidentate motif. This indicates that our previous studies on the role of these two tyrosines in transformation and signaling via the PI3K and ERK pathways were inconclusive, because previously we did not recognize the potential for activation via the minor site. To address this problem we decided to use the above mentioned inhibitors of these two pathways. First, we obtained two cell lines stably-transformed by the temperature-sensitive variant of V-SEA: V-SEA-RAT1, a clone produced by co-transfecting Rat-1 ®broblasts with V-SEA and neomycin resistance gene, and V-SEA-3T3, a cell line produced by infecting NIH3T3 cells with a retrovirus expressing V-SEA (see Materials and methods). Both cell lines displayed an elongated and spindle-shaped morphology with networked and refractile appearance characteristic of transformed cells. When tested for temperature sensitivity by incubation at the non-permissive 398C, cells became¯attened acquiring a morphology reminiscent of the parent Rat-1 or NIH3T3 ®broblast (Figure 4a ). V-SEA-transformed cell lines grow well and maintain the acquired phenotype at 358C, but lose this phenotype at 398C, a temperature at which the V-SEA tyrosine kinase becomes dysfunctional. These results demonstrated the speci®city of the transformation.
Next, we evaluated the biological signi®cance of the Ras-ERK and PI3K-Akt pathways in V-SEA-induced transformation by employing PD98059, a speci®c MEK inhibitor and LY294002, a speci®c PI3K inhibitor. Before actual treatment studies, we carried out titration studies to determine the concentration of each drug that would cause speci®c inhibition without causing other side eects. Both cell lines were treated with either drug for 48 h at concentrations ranging from 10 to 100 mM and lysates prepared from these cells were analysed by immunoblotting with antiphospho-ERK1/2 and anti-phospho-Akt antibodies. The PD compound inhibited only ERK1/2 phosphorylation, but not Akt phosphorylation even at the highest concentration used. The vice versa was true for the LY compound: it inhibited only Akt phosphorylation at the highest concentration used (Figure 4b , data presented was a representative of the experiments with V-SEA-RAT1 and similar results were obtained with V-SEA-3T3). In both cases a 20 mM concentration was sucient to cause speci®c inhibition comparable to basal level and thus, this concentration was used for further studies. Treatment of V-SEA-RAT1 or V-SEA-3T3 with the PD98059 compound caused reversion of the transformed phenotype similar to that seen when cells were incubated at 398C. This morphological change became apparent as early as 24 h and by 72 h, the process of reversion was apparently complete ( Figure 5 , middle panel in both cell lines). Furthermore, PD-treated cells did not seem to have increased in density/population in the 72 h incubation period, but each cell occupied a much larger area due to¯attening (compare top and middle panels in both cell lines at 48 and 72 h). On the other hand, LY treatment did not cause any appreciable morphological change to the transformed phenotype ( Figure 5 , lower panel in both cell lines), but showed a similar eect on cell population/density (compare all panels at 48 and 72 h). These results suggest that blocking the Ras-ERK pathway aects both morphology and cell growth, whereas blocking the PI3K-Akt pathway aects primarily cell growth. Furthermore, they demonstrate that constitutive acti- Figure 5 The eect of PD90859 and LY294002 on morphology and cell growth. V-SEA-RAT1 or V-SEA-3T3 cells were left untreated (upper panels) or treated with 20 mM PD98059 (middle panels) or LY290042 (lower panels) for various lengths of time ranging from 24 to 72 h. Pictures were taken as described in Materials and methods under 106 objective. Note that both drugs inhibited cell proliferation however, signi®cant change in morphology was caused only by PD98059 (also see Figure 6a for both cell types). The pictures presented were representatives of ®ve independent experiments vation of these pathways is essential for the maintenance of transformed phenotype.
The effect of PD98059 and LY294002 on cell number and ERK and Akt phosphorylation
Having shown the eect of these drugs on the morphology and density of the V-SEA-RAT1 and the V-SEA-3T3 cell lines, we conducted time-course treatment studies to demonstrate the eect of these drugs on cell growth by determining cell number. Mock-treated cells multiplied *3.5-fold over the initial value in 72 h, whereas cells treated with the PD or LY compound did not show any signi®cant increase in number (Figure 6a ). To provide further insight on temporal relationship between the onset of ERK and PI3K inhibition and the occurrence of morphological and/or proliferative changes, we carried out additional time-course studies that include shorter time points than the previous ones and analysed lysates prepared from these cells for phosphorylation state of ERK1/2 and Akt. Reduction in the amount of phosphorylated ERK1/2 or Akt occurred 4 h after addition of the respective inhibitor, and reached basal levels before or at 12 h (Figure 6b ). These results suggest that either compound alone is capable of inhibiting the prolifera- PD98059 and LY294002 inhibit colony formation by V-SEA-transformed cell lines
It was previously shown that V-SEA-transformed Rat-1 cells form colonies in soft agar (Park and Hayman, 1999) . In this study, we investigated the eect of PD and LY compounds on the ability of the V-SEA-RAT1 or V-SEA-3T3 cell lines to form colonies in soft agar. Untreated V-SEA-RAT1 cells formed 5610 3 colonies per 10 5 cells, whereas PD or LY compound-treated cells formed only 0.5610 3 (10-fold less colonies) (Table  1) . Furthermore, colonies formed by drug-treated cells were much smaller in size (Figure 7) . Similar results were obtained with the V-SEA-3T3 cells (data not shown). Since colony size for most part is dependent on cell number, these results once again con®rm that the PD and LY compounds inhibit cell proliferation by blocking the Ras-ERK and the P13K-Akt pathways, respectively.
Involvement of Gab2 in signaling by the V-SEA oncogene
Single tyrosine-to-phenylalanine V-SEA mutants were still capable of transforming cells (Park and Hayman, 1999 ) and yet the inhibitor experiments indicate that the PI3K and ERK pathways are essential for transformation. We reasoned that this might be explained by the overlap exhibited by each tyrosine residue in mediating the induction of these signaling pathways. This possibility is consistent with the ®ndings presented in Figure 3a ,b where Y557F was still able to induce *1.8-fold over basal PI3K activity, and Y564F *2-fold over basal ERK activity. The activation of the ERK pathway via Y557 could be explained by this residue being contained within a weak Grb2-binding consensus motif (see Discussion for details). To address the issue of the activation of the PI3K pathway independently of the Y557 site, we explored the possibility of an adaptor being involved.
The two logical candidates were the Gab1 and Gab2, adaptor proteins of the insulin receptor substrate family, which are known to be important for PI3K activation induced by several growth factors and cytokines (Hibi and Hirano, 2000; Zhao et al., 1999; Wichrema et al., 1999; Schaeper et al., 2000; Gu et al., 2000; Nishida et al., 1999) . We conducted immunoprecipitation/immunoblot analysis of lysates prepared from the V-SEA-3T3 and V-SEA-RAT1 cells and their untransformed counter parts (data presented was from NIH3T3 and V-SEA-3T3 cells; similar results were obtained with Rat-1 and V-SEA-RAT1 cells).
Several tyrosine phosphorylated bands that correspond in molecular weight to Gab2 and the unprocessed (gp155) and processed (gp70) forms of V-SEA were detected in the anti-Gab2 and anti-p85 immunoprecipitates of V-SEA-3T3 cells (Figure 8 , top panel, lanes 5 and 6, respectively). In the anti-Gab1 immunoprecipitate, however, only one band that was phosphorylated slightly higher than basal was detected (lane 4). No signi®cantly tyrosine-phosphorylated bands were detected in the control NIH3T3 cells (lanes 1 to 3). Reprobing of the membrane with anti-p85 antibody showed that the p85 subunit of PI3K was present in the anti-Gab2 and anti-p85, but not in the anti-Gab1 immunoprecipitates suggesting that Gab2 and PI3K interact in vivo in cells transformed by V-SEA (Figure 8 , middle panel, lanes 4, 5 and 6). Further reprobing of the membrane with anti-M45 tag antibody that detect the unprocessed form of V-SEA, gp155, showed that V-SEA was present in both antiGab2 and anti-p85, but not in anti-Gab1 immunoprecipitates (Figure 8, lower panel, lanes 4, 5 and 6 ). The tyrosine phosphatase SHP2 and SH2-containing collagen-like protein (SHC), proteins commonly found in RTK-induced signaling complexes, were also detected V-SEA-RAT1 or V-SEA-3T3 cells were suspended in 3 ml growth media by tyrpsinization. Agar was added to a ®nal concentration of 0.3% and the mixture was immediately seeded onto an agar overlay in 6 cm plate. For drug treatment, the PD or LY compound was added to a ®nal concentration of 20 mM. The plates were then incubated for 6 days after which colony size and number were determined. The results shown were averages of three independent experiments from V-SEA-RAT1 cells in the anti-Gab2 or anti-p85 immunoprecipitates (data not shown). These results suggest that a multimeric signaling complex that involves V-SEA, Gab2, PI3K, SHP2 and SHC is formed in these cells. This complex would potentially explain the activation of PI3K independently of Y557.
Discussion
Ligand binding to a RTK elicits receptor dimerization, activation of the intrinsic tyrosine kinase, autophosphorylation of conserved tyrosine residues and recruitment of SH2/PTB domain-containing proteins, a critical step in growth factor signaling. For instance, the bidentate tyrosine phosphorylation motif in the MET tyrosine kinase receptor family (MET, RON and SEA) plays critical roles by mediating the interaction of these receptors with SH2-domain containing signaling proteins such as Grb2, PI3K, SHP2 and SHC (Ponzetto et al., 1993; Graziani et al., 1991; Tulasne et al., 1999) . In the V-SEA oncogene, the two tyrosines in the bidentate motif, designated as Y557 and Y564, serve as docking sites for the p85 subunit of PI3K, Grb2 and the tyrosine phosphatase, SHP2 (Park and Hayman, 1999 ). In the current study, we demonstrated that the interaction of PI3K and Grb2 with V-SEA results in the activation of the PI3K/Akt and Ras-ERK signaling pathways, respectively. Very importantly, we demonstrated that the concomitant functioning of multiple signaling pathways that at least include the Ras-ERK and PI3K-Akt pathways is required for V-SEA-induced Rat-1 cells transformation and/or enhanced proliferation. PI3K becomes activated upon engagement of the SH2 domain of the p85 subunit to phosphotyrosines either on RTKs or their substrates (Pawson, 1995; Cantley et al., 1991; Baker et al., 1992; RordorfNikolic et al., 1995) , which in turn induces activation of the downstream eector protein, Akt (Alessi et al., 1997; Stephens et al., 1998; Anderson et al., 1998a ). In the current study, we demonstrated that V-SEAinduced activation of the PI3K-Akt pathway was primarily Y557 dependent and to a lesser degree Y564 dependent, and that the dierence between V-SEA-associated and direct lipid kinase activity was minimal. These results suggest that direct or indirect interaction between V-SEA and PI3K is necessary for V-SEA-induced PI3K activation. Furthermore, the results with Y557F mutant indicate that *20 ± 25% activation of PI3K occurs via an indirect mechanisms most probably via the adaptor protein Gab2 (see Figure 8 and the Discussion below).
The dependence of V-SEA-induced ERK1/2 activation primarily on Y564 points to the importance of V-SEA-Grb2 interaction in such biochemical events. The partial activation observed with Y557 2 and Y564F (with two and one intact Y557, respectively) may be explained by the presence of asparagine residue in the Y+2 position, which is critical for Grb2 binding, sandwiched by non-ideal (for Grb2 binding) residues in the Y+1 and Y+3 positions thus acting as weak anity binding site. Furthermore, this might explain why Y564F was still capable of transforming Rat-1 ®broblasts (Park and Hayman, 1999) . These results are in agreement with other reports on the MET receptor, a family member of SEA, which showed that mutation of asparagine to histidine, a critical residue for Grb2 binding, abrogated hepatocyte growth factor (HGF)-induced cellular responses (Ponzetto et al., 1996) . The ®nding that the dominant negative form of Ras (N17-Ras), but not WT-Ras, inhibited V-SEA-induced ERK1/2 phosphorylation (Figure 3b) shows the importance of the Grb2-Ras axis in V-SEA-induced ERK1/2 phosphorylation. Furthermore, the results with N17-Ras extend the previous observation that micro-injection of the Grb2 SH2 domain blocked transformation (Park and Hayman, 1999) , since this fusion protein would not only block Grb2 binding but also the association of every signaling molecule that would interact with the Grb2-binding site. Therefore Figure 8 Immunoprecipitation/immunoblot analysis of Gab2 involvement in V-SEA signaling. Lysates prepared from V-SEA-RAT1, V-SEA-3T3 or their untransformed counter parts were subjected to anti-Gab1 (lanes 1 and 4) , anti-Gab2 (lanes 2 and 5) or anti-PI3K (p85) (lanes 3 and 6) immunoprecipitation and then to immunoblot analysis with anti-pY (4G10, upper panel), antip85 (middle panel) or anti-M45 (a tag for gp155, the unprocessed form of V-SEA, lower panel). Lanes 1 ± 3 were from NIH3T3 and 4 ± 6 from V-SEA-3T3. The data presented was a representative of three independent experiments in NIH3T3 and V-SEA-3T3. Similar results were obtained in V-SEA-RAT1 and Rat-1 cells
Transformation by the V-SEA TK oncogene Y Agazie et al although Grb2 is an adaptor protein known to link RTKs to Ras-ERK pathway (Lowenstein et al., 1992; Gale et al., 1993 ) the micro-injection experiments did not speci®cally show that this was due to an inhibition of this pathway. When the PI3K-Akt and Ras-ERK studies are put together, they suggest that Y577 and Y564 primarily mediate activation of PI3K and ERK, respectively, but with each having the capability to weakly activate the other pathway. This residual eect on the other pathway might explain whey RAT-1 cells stably expressing single tyrosine-to-phenylalanine mutants of V-SEA were able to form colonies in soft agar, whereas those expressing the double mutant lacking both tyrosines did not (Park and Hayman, 1999) . Recent reports show that the mechanism by which the PI3K-Akt pathway promotes cell survival is by suppressing proapoptotic and promoting prosurvival pathways (Brunet et al., 1999; Datta et al., 2000; Reed, 1998; Fan et al., 2000; Anderson et al., 1998b; Kennedy et al., 1999) . In addition, it was shown that increased PI3K activity leads to proliferative disorders, transformation and tumor generation (Jimenez et al., 1998; Borlado et al., 2000; Jiang et al., 2000) . For instance, vp3k or v-Akt, constitutively-activated forms of PI3K and c-Akt due to fusion with viral Gag sequences (Chang et al., 1997; Aoki et al., 2000; Tang et al., 2000) , induce cell transformation. Thus, activation of the PI3K-Akt pathways could be part and parcel of the process of V-SEA-induced transformation.
The V-SEA-RAT1 and V-SEA-3T3 cell lines were generated by transforming Rat-1 and NIH3T3 cells with the temperature-sensitive variant of V-SEA, respectively. A more speci®c criteria used to characterize cells transformed with this construct is incubation at a non-permissive temperature (398C), which causes reversion of the transformed phenotype. Indeed, incubation of the V-SEA-RAT1 and V-SEA-3T3 cells at 398C caused reversion clearly demonstrating the speci®city of the transformation ( Figure  4a ). Treatment of these cells with PD98059 that speci®cally inhibit MEK, the upstream kinase responsible for phosphorylating ERK1/2 (Crews et al., 1992; Cowley et al., 1994) , blocked cell growth, reversed the transformed phenotype and inhibited colony formation in soft agar. On the other hand, inhibition of the PI3K with LY294002 blocked cell growth and as well inhibited the ability to form colonies in soft agar. When these results are put together, the following conclusions could be drawn: (a) the Ras-ERK pathway regulates both morphology and cell growth, whereas the PI3K-Akt pathway primarily regulates cell growth and/or survival; (b) each pathway is critical for V-SEA-induced transformation and/or cell growth, but neither alone is sucient since inhibition of one abrogates this potential; and (c) a coordinated functioning of at least the PI3K-Akt and Ras-ERK pathways is absolutely essential for the oncogenicity of V-SEA. Thus, the mechanisms by which the V-SEA oncogene causes sarcoma, erythroblastosis and anemia could be by activating the Ras-ERK and the PI3K-Akt pathways in a manner that exceeds the cells' normal regulatory mechanism. Furthermore, our ®ndings support a previous report, which showed that simultaneous activation of Grb2 and PI3K is essential for MET-mediated metastasis (Bardelli et al., 1999) .
Activation of PI3K by the MET tyrosine kinase receptor requires Gab1 and that this interaction is essential for its transformation potential (Schaeper et al., 2000; Maroun et al., 1999; Ponzetto et al., 1996) . Since MET and SEA belong to the same family, we examined the involvement of Gab1/Gab2 in V-SEA signaling with the aim to come up with a possible explanation why Y557F was still capable of transforming cells (Park and Hayman, 1999) . Surprisingly, we found that it is Gab2, not Gab1, that became heavily tyrosine phosphorylated in V-SEA-transformed cell lines. More importantly, Gab2 interacts with V-SEA and PI3K in vivo and mediates formation of a multimeric signaling complex that involves V-SEA, Gab2 and PI3K. Therefore, the ability of Y557F to still transform cells may emanate from the involvement of Gab2 that allows the induction of the PI3K pathway independent of Y557. We are currently investigating the mechanism of interaction between Gab2 and V-SEA (direct or indirect or both) and will be published elsewhere.
In conclusion, the results presented in this report show that a concomitant activation of, at least, the Ras-ERK and the PI3K-Akt pathways is absolutely essential for V-SEA-induced transformation and/or proliferation. Furthermore, the ®nding that it is Gab2, but not Gab1, which is involved in signaling by the V-SEA oncogene indicates the presence of subtle dierences between MET and V-SEA (Rordorf-Nikolic et al., 1995 and this report) in their use of downstream targets.
Materials and methods

Cells, cell culture, antibodies, etc
The cell types used in this study were COS-1, Rat-1 ®broblasts, V-SEA-RAT1, NIH3T3 and V-SEA-3T3. All cell lines were grown in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% fetal calf serum. COS-1 and Rat-1 ®broblasts were maintained at 378C with 7% CO 2 , and V-SEA-RAT1 and V-SEA-3T3 at 358C with 7% CO 2 . The SEA-speci®c polyclonal antibody was raised and characterized previously (Knight et al., 1990) . Anti-phosphoor pan-(Akt or ERK2) were purchased from New England Biolabs. HA-tagged ERK2 clone and anti-HA monoclonal antibody were kindly provided by Dr Dafna Bar-Sagi. The PD98059 and LY294002 compounds were purchased from BIOMOL and protein-A or protein-G sepharose beads were from Pharmacia.
Immunoprecipitation and immunoblotting
All immunoprecipitation experiments were performed by overnight incubation at 48C with an additional incubation for 2 h after addition of sepharose beads. Unless otherwise Oncogene Transformation by the V-SEA TK oncogene Y Agazie et al speci®ed, immunocomplexes captured on sepharose beads were washed three times with cell lysis buer and bound proteins eluted by boiling with Laemmli sample buer and then run on 10% denaturing polyacrylamide gel. After transfer onto nitrocellulose, blocking was done by incubation with 3% bovine serum albumin. Primary antibody staining was done overnight at 48C for 2 h at room temperature and secondary antibody staining was for 1 h at room temperature. In all cases, the chemiluminescence method was used for detecting bands. The same gel separation and detection procedures were used for the analysis of total cell lysates.
PI3K immunocomplex kinase assay
V-SEA associated PI3K kinase assay was performed as described previously (Whitman et al., 1985; End et al., 1993; Bornfeldt et al., 1991) with slight modi®cation. Brie¯y, COS-1 cells transfected with wild-type V-SEA (WT-V-SEA) or the various mutants were lysed in HEPES lysis buer containing 25 mM HEPES, pH 7.5, 150 mM sodium pyrophosphate, 50 mM NaF, 5 mM EDTA, 50 mM b-glycerophosphate, 10% glycerol, 1% Triton-X-100, and protease inhibitor cocktail (Roche). After clearing by centrifugation at 10 0006g, lysates were subjected to anti-V-SEA immunoprecipitation and then washed two times with lysis buer, once with LiCl buer (0.5 M LiCl, 100 mM Tris-HCl, pH 7.4) and twice with kinase reaction buer (50 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 5 mM MgCl 2 ). The PI3K kinase reaction was performed in 50 ml total volume containing 200 mg phosphatidylinositol (PI), 100 mg ATP and 10 mCi 32 P-ATP. The reaction mixture was incubated at room temperature for 3 min and stopped by adding 100 ml of 0.1 N HCl. The PI was extracted by adding 200 ml of chloroform : Methanol (in 1 : 1 ratio by volume), brie¯y vortexing, centrifuging, discarding aqueous (upper) phase and washing lower (organic) phase with 1 N HCl : Methanol (in 1 : 1 ratio by volume). After discarding the aqueous phase, the organic phase was spotted onto silica gel plate, and TLC run in chloroform : Methanol : NH 4 OH (in 9 : 7 : 4 ratio by volume) until the front end traveled 3 4 of the plate. The plates were then dried and radioactivity determined by autoradiography or 32 P-quantitation in a phosphoimager.
ERK2 immunocomplex kinase assay
ERK2 kinase assay was performed as described previously (Corbalan-Garcia et al., 1998) with some modi®cation. Brie¯y, COS-1 cells were cotransfected with WT-V-SEA or the various mutants described above and HA-tagged ERK2 (in pCGN expression vector). After 36 h of incubation, cells were serum starved overnight (*12 h) and then lysed in the same buer described for PI3K assay. After clearing by centrifugation at 10 0006g, lysates were subjected to anti-HA immunoprecipitation, washed twice with lysis buer and twice with kinase reaction buer (20 mM Tris-HCl, pH 7.4, 0.5 mM NaVO 4 , 20 mM MgCl 2 , 2 mM MnCl 2 , 20 mM ATP). The ERK2 immunocomplex was resuspended in the kinase buer and the reaction was started by adding 10 mCi g-32 P-ATP and 200 mg/ml myelin basic protein as substrates in 50 ml volume. The reaction mixture was incubated for 30 min at 308C, terminated by adding 26 Laemmli sample buer and resolved by SDS ± PAGE. Radioactivity was determined by autoradiography or phosphoimager using ImageQuant software (Storm 860 phosphoimager, Molecular Dynamics).
Generation of the V-SEA-RAT1 and the V-SEA-3T3 cell lines
The V-SEA-RAT1 cell line was generated by transfecting Rat-1 cells with a temperature-sensitive variant of V-SEA. Brie¯y, Rat-1 ®broblasts were cotransfected with 1 mg each of V-SEA and neomycin resistance gene (pMT2/M45-V-SEA and pRSV-neo) using the FuGENE transfection reagent according to the manufacturer's protocol (BoehringerMannheim) with some modi®cation. After overnight incubation, stable transformants were selected by further incubation for approximately 10 days under neomycin (G418, 500 mg/ ml). Individual clones were then picked, grown separately in 6 cm plates and characterized by analysis of morphological changes and temperature sensitivity.
The V-SEA-3T3 cell line was produced by infecting NIH3T3 cells with a retrovirus expressing V-SEA. Brie¯y, the temperature-sensitive variant of V-SEA was inserted into a retroviral vector termed REBNA/IRES/GFP (kindly provided by Dr Olexi Petrenko, Picower Institute for Medical Research, Manhasset, NY, USA) at the NotI and XhoI sites and transfected into packaging phoenix E cells using the FuGENE transfection reagent. After 72 h of incubation, 2 mg/ml puromycin was added to cells to remove untransfected phoenix cells and at the same time to increase the titer of the virus expressing V-SEA; this viral vector contains the puromycin resistance gene. After 48 h under puromycin, resistant cells were split and incubated in fresh medium until they were con¯uent at which time the supernatant containing the virus was harvested and used to infect NIH3T3 cells in the presence of 5 mg/ml polybrene (Sigma). Titration of the virus on NIH3T3 cells gave MOI of 98% per ml per 10 5 cells in a 3.5 cm plate as determined by Fluorescent Activated cell sorter and as well by examining the green¯uorescence under a¯uorescent microscope. This population of cells was termed V-SEA-3T3 and used for the indicated experiments.
Treatment of the V-SEA-RAT1 and V-SEA-3T3 with PD98059 or LY294002
These cell lines were treated with varying concentration of PD98059 or LY294002 in the growing medium to determine a dose that was just sucient to speci®cally inhibit the respective pathways without causing other side eects (see Results for details). After determining a speci®c dose, both cell lines were treated with either drug for varying periods of time to study morphological changes, to score the eect of these drugs on cell growth and to examine the temporal relationship between the occurrence inhibition and morphological changes. Pictures were taken using a Zeiss Axiovert microscope and cell number was determined by the Coulter counter.
Colony-formation in soft agar
First, 6 cm cell culture plates were overlaid with 0.3% agar (Difco) in the growing medium. Next, the V-SEA-RAT1 or V-SEA-3T3 cells (*10 5 cells per 6 cm plate) in 3 ml growing medium were mixed with melted agar (Difco) to a ®nal concentration of 0.3% and immediately poured onto the agar overlay. After 5 min of incubation at room temperature for the agar to solidify, cells were transferred to a 358C/7% CO 2 incubator. For PD98059 and LY294002 treatment, each compound was added to cells prior to addition of the agar. Three days later, cells were fed with soft agar medium either containing the respective drug or not. Colony size and number was determined after 6 days and pictures taken under Zeiss Axiovert microscope.
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